重症监护室气管插管四种预氧合方法疗效比较:McGrath Mac可视喉镜与Macintosh喉镜(MACMAN)试验数据的回顾性分析
该研究是对多中心随机对照MACMAN试验的事后分析,纳入7个法国ICU中319例需气管插管的危重成人,比较四种预氧合装置(球囊面罩49%、无创通气22%、非重复呼吸面罩22%、高流量鼻氧7%)与插管期间最低脉搏血氧饱和度的关联。结果显示,最低脉搏血氧饱和度的独立相关因素包括SAPS II评分、基线脉搏血氧饱和度、基线PaO2/FIO2比值和喉镜尝试次数。脉搏血氧饱和度低于90%的独立预测因素为基线脉搏血氧饱和度(OR 0.71)和预氧合装置:以球囊面罩为参照,无创通气OR 0.10(95%CI 0.01-0.80),高流量鼻氧OR 5.75(95%CI 1.15-28.75)。作者认为,对于插管前明显低氧血症的患者,无创通气可能值得优先选择。
要点
- 在319例ICU气管插管患者中,预氧合装置与脉搏血氧饱和度低于90%独立相关:以球囊面罩为参照,无创通气OR 0.10(95%CI 0.01-0.80),高流量鼻氧OR 5.75(95%CI 1.15-28.75)。
- 脉搏血氧饱和度低于90%的另一个独立预测因素是基线脉搏血氧饱和度(OR 0.71;95%CI 0.64-0.79;p<0.001)。
- 插管期间最低脉搏血氧饱和度的独立相关因素包括SAPS II评分(p=0.03)、基线脉搏血氧饱和度(p<0.001)、基线PaO2/FIO2比值(p=0.02)和喉镜尝试次数(p=0.001)。
- 作者认为,对于气管插管前明显低氧血症的患者,无创通气可能值得优先选择。
- 作者指出,正在进行的研将进一步阐明危重患者气管插管的最佳预氧合方法。
适用人群与场景
- 7个法国ICU中需气管插管的危重成人,纳入MACMAN试验的371例中的319例。
研究设计与关键结果
- 研究类型:多中心随机对照优效性试验(MACMAN)的事后分析,比较可视喉镜与Macintosh喉镜用于重症气管插管。
- 样本量:319例(MACMAN试验共纳入371例)。
- 预氧合装置分布:球囊面罩157例(49%),无创通气71例(22%),非重复呼吸面罩71例(22%),高流量鼻氧20例(7%)。
- 主要终点:插管期间最低脉搏血氧饱和度;独立相关因素为SAPS II评分(p=0.03)、基线脉搏血氧饱和度(p<0.001)、基线PaO2/FIO2比值(p=0.02)和喉镜尝试次数(p=0.001)。
- 脉搏血氧饱和度低于90%的独立预测因素:基线脉搏血氧饱和度(OR 0.71;95%CI 0.64-0.79;p<0.001);以球囊面罩为参照,非重复呼吸面罩OR 1.10(95%CI 0.25-4.92),无创通气OR 0.10(95%CI 0.01-0.80),高流量鼻氧OR 5.75(95%CI 1.15-28.75)。
证据类型、等级与局限
- 证据类型:多中心随机对照试验的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于气管插管前明显低氧血症的患者,无创通气可能值得优先选择。
- 作者指出,正在进行的研将进一步阐明危重患者气管插管的最佳预氧合方法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Severe hypoxemia is the most common serious adverse event during endotracheal intubation. Preoxygenation is performed routinely as a preventive measure. The relative efficacy of the various available preoxygenation devices is unclear. Here, our objective was to assess associations between preoxygenation devices and pulse oximetry values during endotracheal intubation.
DESIGN: Post hoc analysis of data from a multicenter randomized controlled superiority trial (McGrath Mac Videolaryngoscope Versus Macintosh Laryngoscope [MACMAN]) comparing videolaryngoscopy to Macintosh laryngoscopy for endotracheal intubation in critical care.
SETTING: Seven French ICUs.
PATIENTS: Three-hundred nineteen of the 371 critically ill adults requiring endotracheal intubation who were included in the MACMAN trial.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Minimal pulse oximetry value during endotracheal intubation was the primary endpoint. We also sought risk factors for pulse oximetry below 90%. Of 319 patients, 157 (49%) had bag-valve-mask, 71 (22%) noninvasive ventilation, 71 (22%) non-rebreathing mask, and 20 (7%) high-flow nasal oxygen for preoxygenation. Factors independently associated with minimal pulse oximetry value were the Simplified Acute Physiology Score II severity score (p = 0.03), baseline pulse oximetry (p < 0.001), baseline PaO2/FIO2 ratio (p = 0.02), and number of laryngoscopies (p = 0.001). The only independent predictors of pulse oximetry less than 90% were baseline pulse oximetry (odds ratio, 0.71; 95% CI, 0.64-0.79; p < 0.001) and preoxygenation device: with bag-valve-mask as the reference, odds ratios were 1.10 (95% CI, 0.25-4.92) with non-rebreathing mask, 0.10 (95% CI, 0.01-0.80) with noninvasive ventilation, and 5.75 (95% CI, 1.15-28.75) with high-flow nasal oxygen.
CONCLUSIONS: Our data suggest that the main determinants of hypoxemia during endotracheal intubation may be related to critical illness severity and to preexisting hypoxemia. The differences across preoxygenation methods suggest that noninvasive ventilation may deserve preference in patients with marked hypoxemia before endotracheal intubation. Ongoing studies will provide further clarification about the optimal preoxygenation method for endotracheal intubation in critically ill patients.
参考来源
- Bailly A, Ricard JD, Le Thuaut A, et al. Compared Efficacy of Four Preoxygenation Methods for Intubation in the ICU: Retrospective Analysis of McGrath Mac Videolaryngoscope Versus Macintosh Laryngoscope (MACMAN) Trial Data. Crit Care Med. 2019. PMID: 30707125. doi:10.1097/CCM.0000000000003656
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。